often partially rescued in the mutant cells that contact We previously showed that the Drosophila 14-3-3 prothe germline cysts, however, suggesting that these cells teins, 14-3-3⑀ and 14-3-3/Leonardo (LEO) function as can still respond to germline-dependent apical polarizacofactors for PAR-1 in the Drosophila germline (Benton tion cues. Smaller clones of leo P1188 that arise after epiet al., 2002). These proteins bind to PAR-1, and 14-3-thelium formation display milder and less penetrant de-3⑀ and leo mutant combinations produce identical phefects in morphology and polarity ‫%07ف(‬ abnormal, n ϭ notypes to par-1 mutants in both oocyte determination 30 clones). and A-P axis formation. 14-3-3 proteins regulate the As in the germline, LEO functions redundantly with localization and activity of diverse proteins in a phos-14-3-3⑀ (Benton et al., 2002 
1H and data not shown).
These results indicate that 14-3-3 proteins are re-14-3-3 Is Required with PAR-1 for Epithelial quired for epithelial polarity, suggesting that they also Polarization function as cofactors of PAR-1 in this tissue. PAR-1 still To determine whether 14-3-3 also functions with PAR-1 localizes to the cortex in 14-3-3 mutant follicle cells, in epithelial polarization, we used FLPase/FRT-medihowever, although it is often distributed uniformly in the ated mitotic recombination to compare the phenotypes cells that are unpolarized ( Figure 1I ). Thus, as is in the of par-1 and 14-3-3 mutant clones in the Drosophila germline ( . We therefore took a columnar epithelium around the oocyte ( Figure 1B) .
advantage of the fact that 14-3-3 targets can be effipar-1 null follicle cell clones that are generated before ciently identified in yeast two-hybrid screens, presumthe formation of the follicular epithelium display severe ably because endogenous yeast kinases generate the defects in epithelial organization, and apical-specific essential phosphoepitopes that are required for 14-3-3 proteins, such as aPKC, localize uniformly around the binding. In a two-hybrid screen of candidate proteins cortex of the mutant cells ( Figure 1D ). As described with a known role in cell polarity, we detected a strong previously, smaller clones that arise after epithelium forassociation between 14-3-3 and BAZ (Figure 2A ). mation show qualitatively similar, but less penetrant defects (Cox et al., 2001a; Doerflinger et al., 2003) .
The interaction of BAZ with 14-3-3⑀ is not affected by point mutations in 14-3-3⑀ that impair its association with PAR-1 (F199Y or Y214F), but is completely abolished by mutation of a residue that forms part of the phosphoserine motif binding pocket (E183K) ( Figure 2B ) (Benton et al., 2002) . Thus, 14-3-3 is likely to recognize a phosphoserine-containing motif in BAZ. To map this epitope, we tested smaller fragments of BAZ by yeast two-hybrid assays, and identified two independent 14-3-3 binding sites, which lie near the N and C termini of the protein, flanking the three PDZ domains ( Figure 2C ). These sites were further defined by searching for regions of homology with mammalian and C. elegans PAR-3 that contain conserved serines, and then testing whether these serines are required for 14-3-3 binding by mutating them to nonphosphorylatable alanine ( Figure 2C ). We found that S151 is required for binding to the N-terminal site, which closely matches the canonical 14-3-3 binding consensus sequence, RSXpSXP ( Figure 2D ). The second binding site is abolished by mutating S1083, S1084, or S1085. Although this region does not resemble any of the well-defined consensus 14-3-3 recognition motifs, it is similar to the 14-3-3 binding site in an unrelated protein, PKC (Hausser et al., 1999) ( Figure 2D ). These interactions were confirmed by incubating in vitro translated, wild-type BAZ with amylose beads bound with a bacterially-expressed and purified maltose bindingprotein (MBP):14-3-3⑀ fusion protein. BAZ is precipitated by beads containing this fusion protein, but not MBP alone, indicating that these proteins interact directly. Furthermore, a mutant form of full-length BAZ, in which both of the predicted phosphoserine residues are mutated to alanine (BAZ S151A,S1085A
), fails to bind to MBP:14-3-3⑀, indicating that these are the only 14-3-3 binding sites ( Figure 2E ).
Both of these motifs are perfectly conserved in mPar3, indicating that this protein is also likely to bind 14-3-3 ( Figure 2D ). C. elegans PAR-3 is more divergent, however, and we therefore used the two-hybrid assay to determine whether it associates with the C.elegans 14-3-3 homolog, PAR-5 (Morton et al., 2002). Although we were unable to detect an interaction of PAR-5 with an N-terminal fragment of PAR-3 (data not shown), PAR-5 does bind to the PAR-3 C terminus. Deletion and mutational analysis of PAR-3 mapped the phosphoepitope To determine whether Drosophila PAR-1 can phosphorylate the 14-3-3 binding sites in BAZ, we performed kinase assays, using GFP:PAR-1 immunoprecipitated predictions based upon sequence comparison with PKC ( Figure 2D ), S1085 is the sole phosphorylation from ovaries. GFP:PAR-1 very efficiently phosphorylates both N-terminal and C-terminal fragments of BAZ that target of PAR-1 ( Figure 3B ). To confirm that the observed kinase activity is due span the 14-3-3 binding sites ( Figures 3A and 3B) . Phosphorylation of the N-terminal fragment is specific for to PAR-1, and not a coimmunoprecipitating kinase, we performed kinase assays with MBP:PAR-1 purified from the predicted target serine, S151, as it is completely abolished by mutation of this residue to alanine (Figure bacteria. This recombinant kinase displays the same specificity for S151 and S1085 ( Figure 3C ). Thus, PAR-1 3A). In defining the C-terminal 14-3-3 binding site, we observed that S1083, S1084, and S1085 are all essential directly phosphorylates BAZ to generate the phosphoepitopes that are recognized by 14-3-3. for 14-3-3 binding ( Figure 2C ). However, consistent with The PAR-1 Phosphorylation/14-3-3 Binding Sites apical and lateral domains ( Figure 4E ). In contrast, BAZ S151A,S1085A
:GFP shows an extensive overlap with in BAZ Are Essential for Its Lateral Exclusion in Epithelial Cells PAR-1 along the lateral cortex ( Figure 4F ). Moreover, this nonphosphorylatable BAZ recruits both aPKC and To investigate the in vivo significance of these biochemical interactions, we expressed GFP-tagged mutant ver-PAR-6 to the lateral domain, indicating that neither mutation disrupts complex assembly ( Figure 4G and data sions of BAZ that lack one or both of the PAR-1 phosphorylation/14-3-3 binding sites in the follicular not shown). Thus, S1085 and, to a lesser extent, S151, are required to restrict the BAZ/PAR-6/aPKC complex epithelium with the GAL4/UAS system. We first used the CY2 GAL4 driver, which is expressed in a mosaic to the apical membrane domain, and to maintain their complementary distribution to PAR-1. pattern in the large columnar epithelial cells. As described previously, wild-type BAZ:GFP localizes along Although nonphosphorylatable BAZ induces the ectopic assembly of the BAZ/PAR-6/aPKC complex along the apical cortex, and concentrates at the zonula adherens, although it occasionally extends a short disthe lateral membrane, this has little effect on other aspects of apical-basal polarity. The CRB/SDT/Patj comtance laterally in cells in which the transgene is strongly expressed (Figure 4A overlaps extensively with ectopic BAZ S151A,S1085A
:GFP ( Figure 4H ). As the baz transgenes are only expressed Wild-type BAZ and PAR-1 define nonoverlapping after the establishment of these epithelial asymmetries, 14%, n ϭ 36), and the fusion protein localizes normally in the majority of mutant cells (clones with aberrant these observations suggest either that the laterally localized BAZ/PAR-6/aPKC complex is inactive in these localization ϭ 8%, n ϭ 36) ( Figure 5D ). This weak phenotype is presumably due to the absence of sdt function, cells, or that the apical restriction of the complex is not required to maintain polarity in postmitotic columnar since the wild-type transgene efficiently rescues baz mutant defects. In contrast, BAZ S151A,S1085A
:GFP is signifiepithelial cells. This latter possibility is consistent with the observation that ectodermal epithelia remain polarcantly mislocalized in baz sdt clones, and forms aggregates along the lateral cell cortex (72% clones; n ϭ 29). ized in embryos that lack zygotic BAZ, even when maternal BAZ protein is depleted (Tanentzapf and Tepass, Furthermore, these cells lose their epithelial organization and form multilayers of cells (66% clones, n ϭ 29) 2003).
( Figures 5E and 5F ). Thus, the apical localization of BAZ and epithelial polarity depend on S151 and S1085 in the The PAR-1/14-3-3 Regulatory Sites in BAZ Function absence of SDT, and vice versa, indicating that lateral Redundantly with Apical-Retention Mechanisms exclusion by PAR-1/14-3-3 and apical recruitment by The defects in the localization of BAZ S151A,S1085A
:GFP SDT act redundantly to ensure BAZ localization. prompted us to test whether the functional properties of this protein are also compromised, by assessing its ability to rescue the polarity defects of baz mutant follicle
14-3-3 Binding Inhibits BAZ Complex Assembly
The results above demonstrate that mutations of S151 cell clones. We used the e22c GAL4 line to express both a UAS:FLP transgene and wild-type or mutant baz and S1085 in BAZ lead to the lateral spreading of the BAZ/PAR-6/aPKC complex, suggesting that the PARtransgenes in the follicular stem cells. This allowed us to generate large clones of baz mutant cells, all of which 1-dependent binding of 14-3-3 to these sites inhibits complex formation. We investigated the mechanism of express the baz transgene. In the absence of either transgene, baz mutant cells fail to localize aPKC to the this inhibition by examining the interactions between the components of the BAZ complex in yeast cells. apical cortex or to assemble the zonula adherens, and lose their cuboidal morphology and form multiThe S1085 14-3-3 binding site lies close to a conserved region (CR3) of BAZ/mPar3, which, in mPar3, layers ( Figure 5A) 
:GFP in wild-type cells in young left half of upper graph). This result suggests that the BAZ-C bait is phosphorylated in yeast at S980 by the egg chambers (data not shown). Thus, redundant mechanisms must exist to localize BAZ apically at these early aPKC prey (or endogenous yeast kinases), and indicate that the phosphorylation-dependent regulation of the stages when it is required for polarity.
A candidate mechanism that could function in parallel aPKC interaction with BAZ is likely to be conserved. We assessed the effects of 14-3-3 on this interaction by with the PAR-1/14-3-3 regulatory sites to localize BAZ is recruitment by the apical CRB/SDT/Patj complex, since overexpressing 14-3-3⑀ in a yeast three-hybrid assay ( Figure 6B ). 14-3-3⑀ blocks the interaction between BAZthis has been shown to participate in the maintenance of BAZ localization in embryonic epithelia ( 
PAR-1 Regulation of BAZ in A-P Axis Formation
is also detected laterally. However, the fusion protein is usually excluded from the posterior cortex during stages PAR-1 and 14-3-3 function together during stages 7-9 of oogenesis to define A-P oocyte polarity, but the BAZ/ 9-10 (68%, n ϭ 72) ( Figures 7A and 7D ). This posterior exclusion is intriguing, since PAR-1 is localized to a PAR-6/aPKC complex does not appear to be required for this process (Benton et al., 2002) . Nevertheless, immucrescent at the posterior of the oocyte at these stages, and BAZ:GFP and PAR-1 therefore occupy complemennostainings reveal that the BAZ complex is expressed during these stages, and concentrates along the anterior tary cortical domains, as they do in epithelial cells (Figure 7A) . :GFP is also uniformly distributed around the entire cortex of most wild-type oocytes at this stage (92%, n ϭ 52), and completely overlaps with PAR-1 at the posterior (Figures 7C and 7E) . These results suggest that PAR-1 phosphorylates BAZ:GFP to prevent its accumulation at the posterior of the oocyte.
The observations above raise the possibility that the function of PAR-1 and 14-3-3 in polarizing the oocyte could be mediated by inhibiting BAZ posteriorly. We therefore examined the phenotypic consequences of disrupting this regulation. The expression of wild-type BAZ:GFP has no effect on oocyte polarity, as STAU localizes normally to the posterior pole in 99% of oocytes (n ϭ 66) ( Figure 7D ). In contrast, equivalent levels of BAZ S151A,S1085A
:GFP disrupt STAU localization in about half of the oocytes, and the protein is found in ectopic dots or clouds in the center of the oocyte (35%), or is undetectable (14%) (n ϭ 113) ( Figure 7E) . A very similar phenotype is observed for osk mRNA, which is also mislocalized to ectopic dots in the middle of the oocyte (data not shown). These defects arise from a misorganization of the microtubule cytoskeleton, as a microtubule plus end marker, Kinesin:␤-galactosidase (Kin:␤-gal), mislocalizes to a diffuse cloud in the center of the oocyte, rather than the posterior (Figures 7F and 7G) (Clark  et al., 1994) . Furthermore, bcd mRNA is no longer restricted to the anterior cortex, but extends laterally (Figures 7H and 7I) . Although milder, these defects are qualitatively very similar to the phenotypes of par-1 or 14-3-3 mutants. Together, these observations indicate that PAR-1 antagonizes BAZ localization and function in the oocyte, and suggest that ectopic BAZ activity may contribute to the defects in oocyte A-P polarity in par-1 and 14-3-3 mutants. 
